Karyopharm Therapeutics Inc. (NASDAQ:KPTI) will hold its 2Q20 earnings conference call with the financial community on 4th August 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at www.karyopharm.com
Earnings Expectation
Karyopharm Therapeutics Inc. is expected to report second quarter earnings results, before market open, on Tuesday 4th August 2020. Analysts polled by Thomson Reuters anticipate second quarter loss of $ 0.58 per share. Looking ahead, the full year loss are expected at $ 2.47 per share on the revenues of $ 105.78 million.
Karyopharm Therapeutics Inc., an oncology-focused pharmaceutical company, engages in the discovery, development, and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is developing small molecule selective inhibitor of nuclear export (SINE) compounds that inhibit the nuclear export protein exportin 1. Its lead compound is XPOVIO (selinexor), which has received approval from the Food and Drug Administration in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma, as well as is under review by the European Medicines Agency.
